NKGen Biotech Inc (NASDAQ:NKGN) does about 1.28M shares in volume on a normal day but saw 678092 shares change hands in the recent trading day. The company now has a market cap of 14.81M USD. Its current market price is $0.42, marking an increase of 14.72% compared to the previous close of $0.36. The 52 week high reached by this stock is $4.06 whilst the lowest price level in 52 weeks is $0.20.
NKGen Biotech Inc (NKGN) has a 20-day trading average at $0.2919 and the current price is -89.73% off the 52-week high compared with 105.77% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3427 and its 200-day simple moving average is $1.0462. If we look at the stock’s price movements over the week, volatility stands at 19.94%, which decreases to 14.18% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 61.94 to suggest the stock is neutral.
The current price level is 42.81%, 21.66%, and -60.15% away from its SMA20, SMA50, and SMA200 respectively, with the NKGN price moving below the 50-day SMA on current market day. NKGen Biotech Inc (NKGN) stock is up 43.81% over the week and 19.11% over the past month. Its price is -84.84% year-to-date and -85.52% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
Outstanding shares total 21.89M with insiders holding 42.32% of the shares and institutional holders owning 12.19% of the company’s common stock. The company has a return on equity of -118.66%. The beta has a value of 0.67.
